PATENT CLAIM ANALYSIS

Application Number: 16101298
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["424", "400000"]

Abstract:
The disclosure provides methods for treating psychiatric diseases, such as schizophrenia, in patients with certain gene polymorphisms using antipsychotic drugs, such as risperidone and paliperidone.

Claim (Index 13):
The method of  claim 12 , wherein the 50:50 to 90:10 poly(lactide-co-glycolide) copolymer is an 80:20 poly(lactide-co-glycolide) copolymer.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 96.0
- Lexical Diversity: 1.16
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15122101', '15858525', '12602058', '16016250', '14490034']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7880644469081726
- 35 USC 102 Novelty (BERT): 0.6098730903008363
- Combined Prediction Score: 0.770245311247439
- Mean Citation Score: 317.977906
- Max Citation Score: 348.78464
- Similarity Product: 259.446362421875

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test